Dr. Yarlagadda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8901 CARTI way
Little Rock, AR 72205Phone+1 501-906-3000
Education & Training
University at BuffaloResidency, Internal Medicine, 2010 - 2013
Osmania Medical College NTR UHSClass of 2007
Certifications & Licensure
AR State Medical License 2017 - 2025
NY State Medical License 2013 - 2023
TX State Medical License 2016 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 168 citationsMechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma.Sunilkumar Kakadia, Naveen Yarlagadda, Ramez Awad, Madappa N. Kundranda, Jiaxin Niu
Oncotargets and Therapy. 2018-10-17 - 3 citationsClinical characteristics of testicular extramedullary involvement in multiple myeloma.Meera Mohan, Naveen Yarlagadda, Aniko Szabo, Amrit P. Singh, Sergio Pina Oviedo
American Journal of Hematology. 2021-03-01 - 2 citationsHematological and infectious complications with CD38 antigen targeting monoclonal antibody-based therapies in multiple myeloma: A meta-analysis of randomized control t...Naveen Yarlagadda, Sravani Gundarlapalli, Smriti Sharma, Elizabeth M. Suelzer, Muhammad Bilal Abid
Leukemia Research. 2021-09-25
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
